Suliman Alomar
Overview
Explore the profile of Suliman Alomar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Tamimi J, Alomar S, Aljuaimlani A, Mansour L
Innate Immun
. 2025 Jan;
31:17534259251314774.
PMID: 39828905
Background: Killer immunoglobulin-like receptors (KIRs) are key molecules used by natural killer (NK) cells to interact with target cells. These receptors exhibit extensive genotypic polymorphism which has been associated with...
2.
Alonaizan R, K Alotaibi W, Alsulami A, M Alkhulaifi F, Alomar S
Immunol Invest
. 2024 Dec;
:1-17.
PMID: 39701694
Background: Neurodegenerative diseases (NDs) have caused serious health issues worldwide. A growing body of evidence suggests a correlation between neuroinflammation and abnormal microglial activity with ND symptoms. Microglia survey play...
3.
M Alkhulaifi F, Alonaizan R, Rady A, Alomar S
Heliyon
. 2024 Jul;
10(13):e33754.
PMID: 39040297
Objectives: Acute Lymphoblastic Leukemia (ALL) is a multifactorial disease that results from the interaction between multiple genetic factors. ALL is characterized by uncontrolled production of hematopoietic precursor cells of the...
4.
Mansour L, Alqahtani M, Aljuaimlani A, Al-Tamimi J, Al-Harbi N, Alomar S
Medicina (Kaunas)
. 2024 May;
60(5).
PMID: 38792904
Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled proliferation of immature myeloid cells. Immune checkpoint molecules such as programmed cell death protein 1 (PD-1) and lymphocyte activation...
5.
Patocka J, Wu W, Oleksak P, Jelinkova R, Nepovimova E, Spicanova L, et al.
Heliyon
. 2024 Apr;
10(8):e28795.
PMID: 38644874
Fentanyl is a synthetic μ-opioid receptor agonist approved to treat severe to moderate pain with faster onset of action and about 100 times more potent than morphine. Over last two...
6.
Oleksak P, Nepovimova E, Valko M, Alwasel S, Alomar S, Kuca K
Environ Toxicol Pharmacol
. 2024 Apr;
108:104447.
PMID: 38636744
This review systematically compiles sports-related drugs, substances, and methodologies based on the most frequently detected findings from prohibited lists published annually by the World Anti-Doping Agency (WADA) between 2003 and...
7.
Alqahtani M, Aljuaimlani A, Al-Tamimi J, Alomar S, Mansour L
Hematology
. 2024 Mar;
29(1):2329024.
PMID: 38536023
Background: Immune checkpoints are receptors on the surface of T cells that function crucially in suppressing the immune response, and they are implicated in autoimmunity and cancer diseases. Aim: The...
8.
Alqahtani S, Mahallawi W, Alomar S
Heliyon
. 2024 Mar;
10(6):e27594.
PMID: 38509985
Individuals who are diagnosed with chronic kidney disease, particularly those receiving maintenance hemodialysis treatment, face a greater likelihood of suffering from severe symptoms and fatality due to COVID-19. This study...
9.
Wani A, Singh R, Akhtar N, Prakash A, Nepovimova E, Oleksak P, et al.
Mini Rev Med Chem
. 2024 Jan;
24(16):1496-1520.
PMID: 38265369
Sarcoma is a heterogeneous group of malignancies often resistant to conventional chemotherapy and radiation therapy. The phosphatidylinositol-3-kinase/ protein kinase B /mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway has emerged as...
10.
Alyami A, AlJurayyan A, Alosaimi B, Alkadi H, Alkhulaifi F, Al-Jurayb H, et al.
Int J Immunogenet
. 2023 Dec;
51(1):39-46.
PMID: 38087909
Human leukocyte antigen-G (HLA-G) is classified as non-classical HLA, located in the short arm of chromosome 6 and composed of seven introns and eight exons. The HLA-G gene has a...